The recent disruptions in global distribution have highlighted the necessity of securing vital medications like Ivermectin. Relying on overseas manufacturers exposes countries to significant vulnerabilities, including delivery delays, price fluctuations, and even trade threats. Shifting towards domestic procurement of Ivermectin offers a multitude